Marco Polizzi

Background

About Marco Polizzi

A Pharmaceutical Executive with 30+ years of global pharma business leadership experience. Start-up experience creating numerous new divisions and businesses within both the Brand and Generic Pharma industry.Mr. Polizzi has a proven track record that demonstrates exceptional judgement, skillful management of key relationships, and the strategic thinking, foresight and drive to accomplish major achievements.His career reflects deep experience in the Retail and Institutional markets within Specialty, Brands, Biologics, Rare diseases & Generic Pharmaceutical Industry with a focus on Business development and M&A, Commercial Operations, Clinical and Product Development, Manufacturing, and Logistics and Supply Chain management. His experience also includes Start-Ups, Turn-Arounds and driving growth within Fortune 100 companies. He enjoys a hard-earned reputation as an exceptional leader and industry visionary.CAREER MILESTONES:• Provided leadership and expertise to start and grow Mallinckrodt’s Generic Pharmaceutical business from $8M to $800M to become the 5th largest U.S. Generic Company and #1 in Generic Narcotics.• As the founder and lead executive of Mallinckrodt’s Brand Pharmaceutical business unit created and profitably grew the business from $0M to nearly $100M Operating Income on nearly $200M in Net Sales and from 0 to 238 dedicated employees.• Built a new commercial business (Institutional - Hospital & Specialty Markets) at Sandoz. Grew team from 2 to 40 while leading a ~$1B P&L.• Established a new generic commercial division at JHP Pharma, from scratch. Drove 35% CAGR growth of Injectable business (from $62 to $115) the first two years after joining, following the previous 2-year period of single digit growth.• Created an Enterprise Value greater than 300% of cash invested within 30 months of forming Oakrum Pharma (yielding $30m+ valuation).• As CEO of Paradigm, led a $66M dollar capital raise.• Served on the Board of Directors for several pharmaceutical companies.• Served as an Operational Advisor for multiple Private Equity firms to conduct due diligence for the acquisition of Brand and Generic Pharma companies leading to multiple successful acquisitions. EXPERTISE:Board of DirectorsP & L Management and FinanceBusiness Development & M&A Operations & RegulatoryHR, Team Development and MentoringCompensation & Performance ManagementStrategic Planning & Market DevelopmentSales Leadership & TrainingRaising CapitalClinical and Product Development & PlanningMerger & Acquisition Diligence, Completion, and Integration